SOCT

Optopol Launches New Copernicus+ Spectral Domain OCT

Carleton Ltd. will launch the new Optopol Copernicus Plus Spectral Domain OCT at the BCLA conference in Birmingham. The Copernicus+ is the first new product to be launched since Optopol became a wholly-owned subsidiary of Canon Inc. Tokyo. Based on the proven technology and stability of the Copernicus HR, this new model features a faster work flow, networking capability, enhanced comparison module, and simple, yet intuitive user interface, while the new price tag offers affordability for the optometric practice. The Copernicus+ offers two scanning modes, vitreous and choroid, with 27,000 A-scan per second scanning speed at 5μm. The anterior segment module also performs pachymetry, TISA, and AOD measurements.

“The Copernicus+ represents the first collaboration between Optopol, with their intimate knowledge of and years of experience in Spectral Domain OCT, and Canon, a global leader in technology and innovation,” explains Nick Fitrzyk, Managing Director of Carleton Ltd. “We are confident that this partnership will ensure dynamic product development and strong customer support for the future.”

The Optopol Copernicus-HR ultra high resolution Spectral Domain OCT, offers 52,000 A-scans per second and 3µm axial resolution, and also features a user definable B-scan width up to 10mm and patented spectrometer autocalibration. 

The integrated glaucoma module and Doppler analysis combined with the new 3-dimensional visualisation and the optional anterior segment module makes the Copernicus HR extremely versatile in both practice and clinic. 

A new user interface is easy to use and the improved algorithms ensure a high degree of accuracy and consistency.  User definable reports and cost-effective networking solutions provide the flexibility you require.